- Filings
-
Holdings
- Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
-
Profile
- Financials
Innate Pharma (IPHA)
Company Profile
| Quarter (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 10 |
| Opened positions | 1 |
| Closed positions | 0 |
| Increased positions | 1 |
| Reduced positions | 3 |
| 13F shares | Current |
|---|---|
| Total value | 270.01 mm |
| Total shares | 7.32 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Bpifrance Participations | 7.19 mm | $15.81 mm |
| Exchange Traded Concepts | 77.35 k | $143.10 mm |
| MS Morgan Stanley | 43.52 k | $80.08 mm |
| Citadel Advisors | 11.85 k | $21.93 mm |
| UBS UBS | 3.51 k | $6.46 mm |
| Rhumbline Advisers | 675.00 | $1.25 mm |
| NA.R National Bank of Canada | 450.00 | $828.00 k |
| BCS Barclays | 307.00 | $1.00 k |
| Steward Partners Investment Advisory | 200.00 | $368.00 k |
| Optiver Holding B.V. | 101.00 | $187.00 k |